- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00588796
Study of Fibrinogen Metabolism During Severe Trauma and Burns
February 2, 2015 updated by: United States Army Institute of Surgical Research
Alteration in Fibrinogen Metabolism in Patients With Severe Burns and Traumatic Injuries
To study the fibrinogen metabolic changes in relation to coagulation disorder in patients with severe burns and trauma injuries.
As a result of the burn or trauma injury breakdown of fibrinogen is accelerated.
Study Overview
Status
Completed
Conditions
Detailed Description
In this protocol, we will investigate fibrinogen metabolism in burn and trauma patients, using an 8h infusion of stable isotopes labeled amino acids (1-13C-phenylalanine, 2H5-phenylalanine, and 2H3-ketoisocaporate).
The increase of the labeled amino acids incorporating into fibrinogen during the infusion and the decay of labeled fibrinogen after stopping the isotopes infusion (as measured by GC-MS) will be used to calculate fibrinogen synthesis and degradation.
Stable isotopes are non-radioactive.
Study Type
Observational
Enrollment (Actual)
30
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Burn patients Trauma patients Healthy Volunteers
Description
Inclusion Criteria:
- 20% total body surface area burn or more
- severe trauma with injury severity score greater than 10
- between ages of 18 and 65 years
Exclusion Criteria:
- history of blood clotting disorder
- history of liver disease such as cirrhosis or hepatitis
- pregnant or nursing
- allergic to iodine, shellfish or dye used in X-Rays
- taking long term medications for blood clotting usch as Coumadin or Plavix
- prisoners
- receiving total parenteral nutrition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Healthy Volunteers
|
|
Burn patients
Patients who have sustained burn injury greater than or equal to 20% of total body surface area
|
|
Trauma patients
Patients who have undergone trauma
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
During the flow phase following burn or trauma injury, fibrinogen degradation is accelerated
Time Frame: 7
|
7
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Fibrinogen degradation stimulates fibrinogen synthesis at the expense of whole body protein catabolism
Time Frame: 7 days
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Wenjun Z Martini, PhD, United States Army Institute of Surgical Research
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2005
Primary Completion (Actual)
January 1, 2014
Study Completion (Actual)
January 1, 2014
Study Registration Dates
First Submitted
December 25, 2007
First Submitted That Met QC Criteria
January 8, 2008
First Posted (Estimate)
January 9, 2008
Study Record Updates
Last Update Posted (Estimate)
February 4, 2015
Last Update Submitted That Met QC Criteria
February 2, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-04-017
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.